Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 107 of the 116 references it cites were found in a registry or an index.

SALL4: An Intriguing Therapeutic Target in Cancer Treatment

Open access

Abstract

Spalt-Like Transcription Factor 4 (SALL4) is a critical factor for self-renewal ability and pluripotency of stem cells. On the other hand, various reports show tight relation of SALL4 to cancer occurrence and metastasis. SALL4 exerts its effects not only by inducing gene expression but also repressing a large cluster of genes through interaction with various epigenetic modifiers. Due to high expression of SALL4 in cancer cells and its silence in almost all adult tissues, it is an ideal target for cancer therapy. However, targeting SALL4 meets various challenges. SALL4 is a transcription factor and designing appropriate drug to inhibit this intra-nucleus component is challenging. On the other hand, due to lack of our knowledge on structure of the protein and the suitable active sites, it becomes more difficult to reach the appropriate drugs against SALL4. In this review, we have focused on approaches applied yet to target this oncogene and discuss the potential of degrader systems as new therapeutics to target oncogenes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11162601

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SALL4 is an essential gene for survival of cancer cells. (a) Expression pattern of SALL4 across different cancer types. (b) The dependency score −0.13325 was calculating by getting average from dependency score of 789 different cell lines for SALL4 (the score determines the importance of the gene for survival of cancer cells and how its elimination is lethal for the cells). (c) Categorization of different cell types based on the tissue of origin shows that almost all cancer types have a negative dependency score for SALL4 meaning that they are vulnerable to omission of SALL4.
Figure 1 SALL4 is an essential gene for survival of cancer cells. (a) Expression pattern of SALL4 across different cancer types. (b) The dependency score −0.13325 was calculating by getting average from dependency score of 789 different cell lines for SALL4 (the score determines the importance of the gene for survival of cancer cells and how its elimination is lethal for the cells). (c) Categorization of different cell types based on the tissue of origin shows that almost all cancer types have a negative dependency score for SALL4 meaning that they are vulnerable to omission of SALL4.CC BY · PubMed Central
Figure 2 Scheme of the different drugs suggested to target SALL4 in cancer. OXPHOS: Oxidative phosphorylation, IMiDs: Immunomodulatory imide drugs, PROTAC: Proteolysis-targeting chimaeras.
Figure 2 Scheme of the different drugs suggested to target SALL4 in cancer. OXPHOS: Oxidative phosphorylation, IMiDs: Immunomodulatory imide drugs, PROTAC: Proteolysis-targeting chimaeras.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 116 references

Cited by

See all 35

Metadata

Authors
Moein, S., Tenen, D. G., Amabile, G., & Chai, L.
Affiliations
  • Cancer Science Institute of Singapore (SG)
  • Harvard University (US)
  • Believer Pharmaceuticals, Inc., Wilmington, DE 19801, USA
  • Brigham and Women's Hospital (US)
Corresponding author
  • Tenen, Daniel G.
  • Amabile, Giovanni
  • Chai, Li
Venue
Cells
Publisher
MDPI AG
Published
2022-08-20
Volume
11
Issue
16
Pages
2601
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4292549048
Cited by
35
References
116
Citations by year
2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 3
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of Health (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
  • NIH/NHLBI (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
  • Singapore Ministry of Health’s National Medical Research Council (Singapore Translational Research (STaR) Investigator Award) (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
  • Xiu research fund (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Keywords
SALL4, oncogenes, cancer therapy, therapeutic target, transcription factors, epigenetic regulation, gene repression, stem cell pluripotency, metastasis, drug design
MeSH terms
Adult, Gene Expression Regulation, Humans, Neoplasms, Stem Cells, Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SALL4: An Intriguing Therapeutic Target in Cancer Treatment. https://app.cochat.ai/papers/10.3390/cells11162601
The paper
Moein, S., Tenen, D. G., Amabile, G., & Chai, L. (2022). SALL4: An Intriguing Therapeutic Target in Cancer Treatment. Cells. https://doi.org/10.3390/cells11162601

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.